- JP-listed companies
- JCR Pharmaceuticals Co.,Ltd.
JCR Pharmaceuticals Co.,Ltd.JP:4552
Market cap
¥82.5B
P/E ratio
15.3x
Mar 31, 2013 | Mar 31, 2014 | Mar 31, 2015 | Mar 31, 2016 | Mar 31, 2017 | Mar 31, 2018 | Mar 31, 2019 | Mar 31, 2020 | Mar 31, 2021 | Mar 31, 2022 | Mar 31, 2023 | |
Net sales | 14,100 | 15,706 | 16,856 | 17,438 | 18,085 | 20,594 | 23,160 | 24,781 | 30,085 | 51,082 | 34,343 |
Cost of sales | 5,037 | 5,842 | 5,741 | 6,459 | 5,732 | 6,128 | 6,567 | 7,901 | 7,812 | 10,461 | 8,886 |
Gross profit (loss) | 9,063 | 9,864 | 11,115 | 10,979 | 12,353 | 14,465 | 16,592 | 16,880 | 22,272 | 40,620 | 25,456 |
Selling, general and administrative expenses | 7,912 | 8,318 | 9,100 | 8,826 | 9,991 | 10,681 | 11,625 | 13,635 | 14,003 | 20,686 | 20,480 |
Operating profit (loss) | 1,151 | 1,545 | 2,015 | 2,153 | 2,362 | 3,784 | 4,967 | 3,244 | 8,269 | 19,933 | 4,975 |
Interest income | 36 | 34 | 31 | 27 | 17 | 20 | 20 | 19 | 7 | 7 | 33 |
Dividend income | 19 | 21 | 24 | 23 | 21 | 25 | 25 | 25 | 25 | 28 | 28 |
Foreign exchange gains | 45 | 57 | 55 | 12 | 47 | - | 39 | 8 | 206 | 551 | 387 |
Dividend income | 19 | 21 | 24 | 23 | 21 | 25 | 25 | 25 | 25 | 28 | 28 |
Other | 24 | 38 | 122 | 26 | 133 | 21 | 23 | 28 | 65 | 68 | 91 |
Foreign exchange gains | 45 | 57 | 55 | 12 | 47 | - | 39 | 8 | 206 | 551 | 387 |
Non-operating income | 139 | 241 | 403 | 348 | 236 | 105 | 148 | 81 | 305 | 656 | 541 |
Other | 24 | 38 | 122 | 26 | 133 | 21 | 23 | 28 | 65 | 68 | 91 |
Non-operating income | 139 | 241 | 403 | 348 | 236 | 105 | 148 | 81 | 305 | 656 | 541 |
Interest expenses | 50 | 44 | 38 | 33 | 29 | 27 | 21 | 22 | 42 | 45 | 44 |
Commission expenses | - | - | - | - | - | - | - | - | 11 | 12 | 15 |
Loss on abandonment of inventories | - | - | - | - | - | - | - | - | - | - | 20 |
Other | 15 | 12 | 40 | 25 | 35 | 11 | 7 | 9 | 31 | 18 | 18 |
Non-operating expenses | 133 | 106 | 78 | 58 | 64 | 46 | 47 | 32 | 85 | 77 | 99 |
Ordinary profit (loss) | 1,156 | 1,681 | 2,340 | 2,443 | 2,534 | 3,843 | 5,068 | 3,293 | 8,488 | 20,512 | 5,418 |
Gain on sale of investment securities | - | 119 | - | - | - | - | - | - | - | - | 10 |
Extraordinary income | - | 154 | - | 16 | 21 | 77 | 82 | 131 | 170 | - | 10 |
Loss on disposal of non-current assets | 21 | 20 | 6 | 0 | 3 | 25 | 37 | 2 | 5 | 2 | 16 |
Loss on cancellation of contracts | - | - | - | - | - | - | - | - | - | 1,000 | - |
Other | 3 | 2 | - | - | - | - | 2 | - | - | 105 | - |
Extraordinary losses | 91 | 157 | 6 | 0 | 62 | 25 | 221 | 2 | 5 | 1,108 | 16 |
Profit (loss) before income taxes | 1,065 | 1,677 | 2,334 | 2,459 | 2,493 | 3,895 | 4,928 | 3,422 | 8,653 | 19,404 | 5,412 |
Income taxes - current | 448 | 673 | 371 | 852 | 394 | 964 | 1,169 | 1,017 | 2,836 | 5,549 | 525 |
Income taxes - deferred | -114 | -292 | 281 | -182 | 236 | -139 | 48 | -274 | -1,072 | -663 | 1,099 |
Income taxes | 334 | 381 | 652 | 670 | 630 | 825 | 1,217 | 742 | 1,764 | 4,886 | 1,625 |
Profit (loss) | - | - | 1,682 | 1,790 | 1,863 | 3,069 | 3,710 | 2,679 | 6,888 | 14,517 | 3,787 |
Profit (loss) attributable to non-controlling interests | - | - | 0 | 0 | 0 | - | -4 | 1 | -4 | 10 | 14 |
Profit (loss) attributable to owners of parent | - | - | 1,682 | 1,789 | 1,863 | 3,070 | 3,715 | 2,678 | 6,892 | 14,507 | 3,772 |